Abstract
Published data on the association between GSK3B −50C/T (rs334558) and bipolar disorder (BD) are inconclusive. We performed this meta-analysis to evaluate the relationship of this single-nucleotide polymorphism with the susceptibility, and with the age at onset of BD. A literature search was conducted though PubMed, EMBASE, Web of Science and China National Knowledge Infrastructure databases to identify relevant studies up to February 14, 2014. We identified a total of 6 publications including 1,251 cases and 1,804 controls to investigate the effect of GSK3B −50C/T on BD risk, and found no significant association in any genetic models (C vs. T: OR = 1.03, 95 % CI: 0.92–1.15; CC vs. TT+TC: OR = 1.04, 95 % CI: 0.84–1.28; TC+CC vs. TT: OR = 1.16, 95 % CI: 0.97–1.39; and CC vs. TC vs. TT: OR = 1.08, 95 % CI: 0.96–1.22). Subgroup analysis by ethnicity did not change the results. The association between GSK3B −50C/T and age at onset of BD was explored by 6 identified studies with a total of 659 BD type I patients. Similarly, we did not observe significant results in any genetic models (TC+CC vs. TT: SMD = 0.20, 95 % CI: −0.07 to 0.47; CC vs. TT+TC: SMD = 0.11, 95 % CI: −0.10 to 0.32; CC vs. TT: SMD = 0.32, 95 % CI: −0.13 to 0.77). The power analysis and tests for publication bias ensured the reliability of our results. In summary, this meta-analysis suggests that the functional polymorphism −50C/T within the GSK3B gene promoter is unlikely to relate with BD risk. However, more larger and well-designed studies are still needed to yield a conclusive result on the topic.
Similar content being viewed by others
References
Smoller JW, Finn CT (2003) Family, twin, and adoption studies of bipolar disorder. Am J Med Genet C Semin Med Genet 123C(1):48–58. doi:10.1002/ajmg.c.20013
Kessler RC, Adler L, Ames M, Barkley RA, Birnbaum H, Greenberg P, Johnston JA, Spencer T, Ustun TB (2005) The prevalence and effects of adult attention deficit/hyperactivity disorder on work performance in a nationally representative sample of workers. J Occup Environ Med/Am Coll Occup Environ Med 47(6):565–572
Ketter TA (2010) Diagnostic features, prevalence, and impact of bipolar disorder. J Clin Psychiatry 71(6):e14. doi:10.4088/JCP.8125tx11c
Novick DM, Swartz HA, Frank E (2010) Suicide attempts in bipolar I and bipolar II disorder: a review and meta-analysis of the evidence. Bipolar Disord 12(1):1–9. doi:10.1111/j.1399-5618.2009.00786.x
Chatterton ML, Ke X, Lewis BE, Rajagopalan K, Lazarus A (2008) Impact of bipolar disorder on the family: utilization and cost of health care resources. P & T 33(1):15–34
Kessler RC, Akiskal HS, Ames M, Birnbaum H, Greenberg P, Hirschfeld RM, Jin R, Merikangas KR, Simon GE, Wang PS (2006) Prevalence and effects of mood disorders on work performance in a nationally representative sample of US workers. Am J Psychiatry 163(9):1561–1568. doi:10.1176/appi.ajp.163.9.1561
Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, Schulze TG, Cichon S, Rietschel M, Nothen MM, Georgi A, Schumacher J, Schwarz M, Abou Jamra R, Hofels S, Propping P, Satagopan J, Detera-Wadleigh SD, Hardy J, McMahon FJ (2008) A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 13(2):197–207. doi:10.1038/sj.mp.4002012
Ferreira MA, O’Donovan MC, Meng YA, Jones IR, Ruderfer DM, Jones L, Fan J, Kirov G, Perlis RH, Green EK, Smoller JW, Grozeva D, Stone J, Nikolov I, Chambert K, Hamshere ML, Nimgaonkar VL, Moskvina V, Thase ME, Caesar S, Sachs GS, Franklin J, Gordon-Smith K, Ardlie KG, Gabriel SB, Fraser C, Blumenstiel B, Defelice M, Breen G, Gill M, Morris DW, Elkin A, Muir WJ, McGhee KA, Williamson R, MacIntyre DJ, MacLean AW, St CD, Robinson M, Van Beck M, Pereira AC, Kandaswamy R, McQuillin A, Collier DA, Bass NJ, Young AH, Lawrence J, Ferrier IN, Anjorin A, Farmer A, Curtis D, Scolnick EM, McGuffin P, Daly MJ, Corvin AP, Holmans PA, Blackwood DH, Gurling HM, Owen MJ, Purcell SM, Sklar P, Craddock N (2008) Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 40(9):1056–1058. doi:10.1038/ng.209
Sklar P, Smoller JW, Fan J, Ferreira MA, Perlis RH, Chambert K, Nimgaonkar VL, McQueen MB, Faraone SV, Kirby A, de Bakker PI, Ogdie MN, Thase ME, Sachs GS, Todd-Brown K, Gabriel SB, Sougnez C, Gates C, Blumenstiel B, Defelice M, Ardlie KG, Franklin J, Muir WJ, McGhee KA, MacIntyre DJ, McLean A, VanBeck M, McQuillin A, Bass NJ, Robinson M, Lawrence J, Anjorin A, Curtis D, Scolnick EM, Daly MJ, Blackwood DH, Gurling HM, Purcell SM (2008) Whole-genome association study of bipolar disorder. Mol Psychiatry 13(6):558–569. doi:10.1038/sj.mp.4002151
Smith EN, Bloss CS, Badner JA, Barrett T, Belmonte PL, Berrettini W, Byerley W, Coryell W, Craig D, Edenberg HJ, Eskin E, Foroud T, Gershon E, Greenwood TA, Hipolito M, Koller DL, Lawson WB, Liu C, Lohoff F, McInnis MG, McMahon FJ, Mirel DB, Murray SS, Nievergelt C, Nurnberger J, Nwulia EA, Paschall J, Potash JB, Rice J, Schulze TG, Scheftner W, Panganiban C, Zaitlen N, Zandi PP, Zollner S, Schork NJ, Kelsoe JR (2009) Genome-wide association study of bipolar disorder in European American and African American individuals. Mol Psychiatry 14(8):755–763. doi:10.1038/mp.2009.43
Djurovic S, Gustafsson O, Mattingsdal M, Athanasiu L, Bjella T, Tesli M, Agartz I, Lorentzen S, Melle I, Morken G, Andreassen OA (2010) A genome-wide association study of bipolar disorder in Norwegian individuals, followed by replication in Icelandic sample. J Affect Disord 126(1–2):312–316. doi:10.1016/j.jad.2010.04.007
Sklar P et al (2011) Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 43(10):977–983. doi:10.1038/ng.943
Plyte SE, Hughes K, Nikolakaki E, Pulverer BJ, Woodgett JR (1992) Glycogen synthase kinase-3: functions in oncogenesis and development. Biochim Biophys Acta 1114(2–3):147–162
Forde JE, Dale TC (2007) Glycogen synthase kinase 3: a key regulator of cellular fate. Cell Mol Life Sci 64(15):1930–1944. doi:10.1007/s00018-007-7045-7
Prickaerts J, Moechars D, Cryns K, Lenaerts I, van Craenendonck H, Goris I, Daneels G, Bouwknecht JA, Steckler T (2006) Transgenic mice overexpressing glycogen synthase kinase 3beta: a putative model of hyperactivity and mania. J Neurosci 26(35):9022–9029. doi:10.1523/jneurosci.5216-05.2006
Newton SS, Thome J, Wallace TL, Shirayama Y, Schlesinger L, Sakai N, Chen J, Neve R, Nestler EJ, Duman RS (2002) Inhibition of cAMP response element-binding protein or dynorphin in the nucleus accumbens produces an antidepressant-like effect. J Neurosci 22(24):10883–10890
Inkster B, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P, Matthews PM (2009) Association of GSK3 beta polymorphisms with brain structural changes in major depressive disorder. Arch Gen Psychiatry 66(7):721–728
Kwok JB, Hallupp M, Loy CT, Chan DK, Woo J, Mellick GD, Buchanan DD, Silburn PA, Halliday GM, Schofield PR (2005) GSK3B polymorphisms alter transcription and splicing in Parkinson’s disease. Ann Neurol 58(6):829–839. doi:10.1002/ana.20691
Lachman HM, Pedrosa E, Petruolo OA, Cockerham M, Papolos A, Novak T, Papolos DF, Stopkova P (2007) Increase in GSK3beta gene copy number variation in bipolar disorder. Am J Med Genet B Neuropsychiatr Genet 144B(3):259–265. doi:10.1002/ajmg.b.30498
Szczepankiewicz A, Rybakowski JK, Suwalska A, Skibinska M, Leszczynska-Rodziewicz A, Dmitrzak-Weglarz M, Czerski PM, Hauser J (2006) Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients. World J Biol Psychiatry 7(3):158–161. doi:10.1080/15622970600554711
Serretti A, Benedetti F, Mandelli L, Calati R, Caneva B, Lorenzi C, Fontana V, Colombo C, Smeraldi E (2008) Association between GSK-3beta −50T/C polymorphism and personality and psychotic symptoms in mood disorders. Psychiatry Res 158(2):132–140. doi:10.1016/j.psychres.2007.06.017
Russ C, Lovestone S, Powell JF (2001) Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late onset Alzheimer’s disease. Mol Psychiatry 6(3):320–324. doi:10.1038/sj.mp.4000852
Benedetti F, Bernasconi A, Lorenzi C, Pontiggia A, Serretti A, Colombo C, Smeraldi E (2004) A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci Lett 355(1–2):37–40
Lee KY, Ahn YM, Joo EJ, Jeong SH, Chang JS, Kim SC, Kim YS (2006) No association of two common SNPs at position −1727 A/T, −50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population. Neurosci Lett 395(2):175–178. doi:10.1016/j.neulet.2005.10.059
Nishiguchi N, Breen G, Russ C, Clair D, Collier D (2006) Association analysis of the glycogen synthase kinase-3beta gene in bipolar disorder. Neurosci Lett 394(3):243–245. doi:10.1016/j.neulet.2005.10.042
Szczepankiewicz A, Skibinska M, Hauser J, Slopien A, Leszczynska-Rodziewicz A, Kapelski P, Dmitrzak-Weglarz M, Czerski PM, Rybakowski JK (2006) Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder. Neuropsychobiology 53(1):51–56. doi:10.1159/000090704
Scassellati C, Rotondo A, Bonvicini C, Rossi G, Cassano GB, Gennarelli M (2007) Further evidence on the lack of association between glycogen synthase kinase 3beta gene polymorphisms and bipolar disorder. Psychiatr Genet 17(4):249–250. doi:10.1097/YPG.0b013e328013d8d8
Lee YJ, Kim YK (2011) The impact of glycogen synthase kinase 3beta gene on psychotic mania in bipolar disorder patients. Prog Neuropsychopharmacol Biol Psychiatry 35(5):1303–1308. doi:10.1016/j.pnpbp.2011.04.006
Lin YF, Huang MC, Liu HC (2013) Glycogen synthase kinase 3beta gene polymorphisms may be associated with bipolar I disorder and the therapeutic response to lithium. J Affect Disord 147(1–3):401–406. doi:10.1016/j.jad.2012.08.025
Benedetti F, Serretti A, Colombo C, Lorenzi C, Tubazio V, Smeraldi E (2004) A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. Neurosci Lett 368(2):123–126. doi:10.1016/j.neulet.2004.06.050
Benedetti F, Serretti A, Pontiggia A, Bernasconi A, Lorenzi C, Colombo C, Smeraldi E (2005) Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta −50 T/C SNP. Neurosci Lett 376(1):51–55. doi:10.1016/j.neulet.2004.11.022
Benedetti F, Bollettini I, Barberi I, Radaelli D, Poletti S, Locatelli C, Pirovano A, Lorenzi C, Falini A, Colombo C, Smeraldi E (2013) Lithium and GSK3-beta promoter gene variants influence white matter microstructure in bipolar disorder. Neuropsychopharmacology 38(2):313–327. doi:10.1038/npp.2012.172
Yu KD, Di GH, Fan L, Chen AX, Yang C, Shao ZM (2010) Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects. Breast Cancer Res Treat 122(2):483–488. doi:10.1007/s10549-009-0706-5
Michael JB, Jonathan JD, Dennis GA (1999) Metan-an alternative meta-analysis command. Stata Tech Bull 8(44):4–15
Killeen PR (2005) An alternative to null-hypothesis significance tests. Psychol Sci 16(5):345–353. doi:10.1111/j.0956-7976.2005.01538.x
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560. doi:10.1136/bmj.327.7414.557
Harris RJ, Bradburn MJ, Deeks JJ, Harbord RM, Altman DG, Sterne JAC (2008) Metan: fixed- and random-effects meta-analysis. Stata J 8(1):3–28
Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634
Rybakowski JK, Czerski P, Dmitrzak-Weglarz M, Kliwicki S, Leszczynska-Rodziewicz A, Permoda-Osip A, Skibinska M, Suwalska A, Szczepankiewicz A, Hauser J (2012) Clinical and pathogenic aspects of candidate genes for lithium prophylactic efficacy. J Psychopharmacol (Oxford, England) 26(3):368–373. doi:10.1177/0269881111415736
Benedetti F, Dallaspezia S, Lorenzi C, Pirovano A, Radaelli D, Locatelli C, Poletti S, Colombo C, Smeraldi E (2012) Gene-gene interaction of glycogen synthase kinase 3-beta and serotonin transporter on human antidepressant response to sleep deprivation. J Affect Disord 136(3):514–519. doi:10.1016/j.jad.2011.10.039
Blasi G, Napolitano F, Ursini G, Di Giorgio A, Caforio G, Taurisano P, Fazio L, Gelao B, Attrotto MT, Colagiorgio L, Todarello G, Piva F, Papazacharias A, Masellis R, Mancini M, Porcelli A, Romano R, Rampino A, Quarto T, Giulietti M, Lipska BK, Kleinman JE, Popolizio T, Weinberger DR, Usiello A, Bertolino A (2013) Association of GSK-3beta genetic variation with GSK-3beta expression, prefrontal cortical thickness, prefrontal physiology, and schizophrenia. Am J Psychiatry 170(8):868–876. doi:10.1176/appi.ajp.2012.12070908
Conflict of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Additional information
Guodi Chen and Jun Tang contributed equally to this study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
11033_2014_3441_MOESM2_ESM.tif
Supplementary Fig. S1 Forest plots and Begg’s funnel plots for the overall association between GSK3B −50C/T and bipolar disorder risk in other genetic models. a–b Forest plot (a) and Begg’s funnel plot (b) in the CC versus TT+TC model (the recessive model). c–d Forest plot (c) and Begg’s funnel plot (d) in the TC+CC versus TT model (the dominant model). e–f Forest plot (e) and Begg’s funnel plot (f) in the CC versus TC versus TT model (the log-additive model). (TIFF 801 kb)
11033_2014_3441_MOESM3_ESM.tif
Supplementary Fig. S2 Forest plots and Begg’s funnel plots for the overall association between GSK3B −50C/T and the age at onset of disorder risk in other genetic models. a–b Forest plot (a) and Begg’s funnel plot (b) in the CC versus TT+TC model (the recessive model). c–d Forest plot (c) and Begg’s funnel plot (d) in the CC versus TT model. (TIFF 537 kb)
11033_2014_3441_MOESM4_ESM.tif
Supplementary Fig. S3 Statistical power analysis. It presents the study power for detecting a significant association between GSK3B −50C/T and bipolar disorder risk based on the allelic data in this meta-analysis (α = 0.05, controls/cases ratio = 1.44, and C allele frequency in controls = 0.441). The power in our study is 45, 76 and 94 % when OR is 1.10, 1.15 and 1.20, respectively. (TIFF 607 kb)
Rights and permissions
About this article
Cite this article
Chen, G., Tang, J., Yu, G. et al. Meta-analysis demonstrates lack of association of the GSK3B −50C/T polymorphism with risk of bipolar disorder. Mol Biol Rep 41, 5711–5718 (2014). https://doi.org/10.1007/s11033-014-3441-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-014-3441-x